277 related articles for article (PubMed ID: 27543977)
41. How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers?
Zhou M; Aydin H; Kanane H; Epstein JI
Am J Surg Pathol; 2004 Feb; 28(2):239-43. PubMed ID: 15043314
[TBL] [Abstract][Full Text] [Related]
42. Utility of immunohistochemistry for alpha-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy.
Farinola MA; Epstein JI
Hum Pathol; 2004 Oct; 35(10):1272-8. PubMed ID: 15492996
[TBL] [Abstract][Full Text] [Related]
43. The relation of beclin 1 and bcl-2 expressions in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue microarray study.
Baspinar S; Bircan S; Orhan H; Kapucuoglu N; Bozkurt KK
Pathol Res Pract; 2014 Jul; 210(7):412-8. PubMed ID: 24690321
[TBL] [Abstract][Full Text] [Related]
44. Elevated expression of angiogenin in prostate cancer and its precursors.
Katona TM; Neubauer BL; Iversen PW; Zhang S; Baldridge LA; Cheng L
Clin Cancer Res; 2005 Dec; 11(23):8358-63. PubMed ID: 16322296
[TBL] [Abstract][Full Text] [Related]
45. CDK19 as a diagnostic marker for high-grade prostatic intraepithelial neoplasia.
Offermann A; Joerg V; Hupe MC; Becker F; Müller M; Brägelmann J; Kirfel J; Merseburger AS; Sailer V; Tharun L; Perner S
Hum Pathol; 2021 Nov; 117():60-67. PubMed ID: 34314763
[TBL] [Abstract][Full Text] [Related]
46. Global expression of AMACR transcripts predicts risk for prostate cancer - a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate.
Alinezhad S; Väänänen RM; Ochoa NT; Vertosick EA; Bjartell A; Boström PJ; Taimen P; Pettersson K
BMC Urol; 2016 Feb; 16():10. PubMed ID: 26928323
[TBL] [Abstract][Full Text] [Related]
47. GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics.
Kristiansen G; Fritzsche FR; Wassermann K; Jäger C; Tölls A; Lein M; Stephan C; Jung K; Pilarsky C; Dietel M; Moch H
Br J Cancer; 2008 Sep; 99(6):939-48. PubMed ID: 18781151
[TBL] [Abstract][Full Text] [Related]
48. Diagnostic utility of p63 and α-methyl acyl Co A racemase in resolving suspicious foci in prostatic needle biopsy and transurethral resection of prostate specimens.
Singh V; Manu V; Malik A; Dutta V; Mani NS; Patrikar S
J Cancer Res Ther; 2014; 10(3):686-92. PubMed ID: 25313761
[TBL] [Abstract][Full Text] [Related]
49. Intraductal Carcinoma of the Prostate: Morphologic Features, Differential Diagnoses, Significance, and Reporting Practices.
Magers M; Kunju LP; Wu A
Arch Pathol Lab Med; 2015 Oct; 139(10):1234-41. PubMed ID: 26414467
[TBL] [Abstract][Full Text] [Related]
50. Foamy gland carcinoma of the prostate in needle biopsy: incidence, Gleason grade, and comparative α-methylacyl-CoA racemase vs. ERG expression.
Warrick JI; Humphrey PA
Am J Surg Pathol; 2013 Nov; 37(11):1709-14. PubMed ID: 23797726
[TBL] [Abstract][Full Text] [Related]
51. Overexpression of IGBFB2 is a marker for malignant transformation in prostate epithelium.
Richardsen E; Ukkonen T; Bjørnsen T; Mortensen E; Egevad L; Busch C
Virchows Arch; 2003 Apr; 442(4):329-35. PubMed ID: 12684767
[TBL] [Abstract][Full Text] [Related]
52. Florid basal cell hyperplasia of the prostate: a histological, ultrastructural, and immunohistochemical analysis.
Yang XJ; Tretiakova MS; Sengupta E; Gong C; Jiang Z
Hum Pathol; 2003 May; 34(5):462-70. PubMed ID: 12792920
[TBL] [Abstract][Full Text] [Related]
53. IGFBP2 as an immunohistochemical marker for prostatic adenocarcinoma.
Ambrosini-Spaltro A; Farnedi A; Montironi R; Foschini MP
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):318-28. PubMed ID: 21304397
[TBL] [Abstract][Full Text] [Related]
54. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
[TBL] [Abstract][Full Text] [Related]
55. Heterogeneous expression of alpha-methylacyl-CoA racemase in prostatic cancer correlates with Gleason score.
Murphy AJ; Hughes CA; Lannigan G; Sheils O; O'Leary J; Loftus B
Histopathology; 2007 Jan; 50(2):243-51. PubMed ID: 17222253
[TBL] [Abstract][Full Text] [Related]
56. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.
Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ
Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460
[TBL] [Abstract][Full Text] [Related]
57. CIP2A expression in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue mıcroarray study.
Celikden SG; Baspinar S; Ozturk SA; Karaibrahimoglu A
Malays J Pathol; 2020 Aug; 42(2):227-236. PubMed ID: 32860375
[TBL] [Abstract][Full Text] [Related]
58. Detection of prostate cancer by alpha-methylacyl CoA racemase (P504S) in needle biopsy specimens previously reported as negative for malignancy.
Carswell BM; Woda BA; Wang X; Li C; Dresser K; Jiang Z
Histopathology; 2006 May; 48(6):668-73. PubMed ID: 16681682
[TBL] [Abstract][Full Text] [Related]
59. Prognostic significance of alpha-methylacyl-coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsies.
Stewart J; Fleshner N; Cole H; Toi A; Sweet J
J Urol; 2008 May; 179(5):1751-5; discussion 1755. PubMed ID: 18343427
[TBL] [Abstract][Full Text] [Related]
60. [Fatty acid synthase in the diagnosis of prostate neoplasms].
Allina DO; Andreeva YY; Zavalishina LE; Moskvina LV; Frank GA
Arkh Patol; 2017; 79(2):10-14. PubMed ID: 28418352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
